News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Biotech Bay
Gilead Sciences, Inc. to Present at the Bank of America Merrill Lynch 2010 Healthcare Conference on Thursday, May 13
May 7, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq:GILD) today announced that its corporate presentation will be webcast from the Banc of America Merrill Lynch Healthcare Conference in New York.
Twitter
LinkedIn
Facebook
Email
Print
Events
Gilead Sciences, Inc.
MORE ON THIS TOPIC
Podcast
Lilly tees off with Novo at ADA, GSK’s $10.6B deal, FDA reform continues in Makary’s absence
June 10, 2026
·
2 min read
·
Jef Akst
Diabetes
ADA: Lilly bests Novo again, takes GLP-1 pill Foundayo to FDA for diabetes approval
June 9, 2026
·
2 min read
·
Tristan Manalac
Obesity
ADA: Novo boasts deep pipeline, ‘breadth of assets’ after analysts award Lilly weight loss gold
June 8, 2026
·
5 min read
·
Heather McKenzie
Obesity
ADA: Boehringer leans on fat mass benefits as obesity bet delivers ‘less competitive’ weight reduction
June 8, 2026
·
2 min read
·
Tristan Manalac
